R&I: Bipolar Disorder Market - Size, Share, Global Trends, 2014 - PowerPoint PPT Presentation

About This Presentation
Title:

R&I: Bipolar Disorder Market - Size, Share, Global Trends, 2014

Description:

This report provides comprehensive information on the therapeutic development for Bipolar Disorder (Manic Depression), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Detailed report at: – PowerPoint PPT presentation

Number of Views:49

less

Transcript and Presenter's Notes

Title: R&I: Bipolar Disorder Market - Size, Share, Global Trends, 2014


1

Bipolar Disorder (Manic Depression) - Pipeline
Review, H2 2014

No of pages 129
Publish Date October 2014
2
Description


This report provides comprehensive information on
the therapeutic development for Bipolar Disorder
(Manic Depression), complete with comparative
analysis at various stages, therapeutics
assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured
news and press releases. It also reviews key
players involved in the therapeutic development
for Bipolar Disorder (Manic Depression) and
special features on late-stage and discontinued
projects. Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
3
Scope of the Report

  • The report provides a snapshot of the global
    therapeutic landscape of Bipolar Disorder (Manic
    Depression)
  • The report reviews key pipeline products under
    drug profile section which includes, product
    description, MoA and RD brief, licensing and
    collaboration details other developmental
    activities
  • The report reviews key players involved in the
    therapeutics development for Bipolar Disorder
    (Manic Depression) and enlists all their major
    and minor projects
  • The report summarizes all the dormant and
    discontinued pipeline projects
  • A review of the Bipolar Disorder (Manic
    Depression) products under development by
    companies and universities/research institutes
    based on information derived from company and
    industry-specific sources.
  • Detailed Report at http//www.reportsandintellige
    nce.com/bipolar-disorder-manic-depression-pipeline
    -review-h2-2014-market

4
Reasons to buy

  •  Provides strategically significant competitor
    information, analysis, and insights to formulate
    effective RD development strategies
  • Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding
    the focus areas of leading companies
  • Identify and understand important and diverse
    types of therapeutics under development for
    Bipolar Disorder (Manic Depression)
  • Plan mergers and acquisitions effectively by
    identifying key players of the most promising
    pipeline
  • Devise corrective measures for pipeline projects
    by understanding Bipolar Disorder (Manic
    Depression) pipeline depth and focus of
    Indication therapeutics.

5
Table Of Content
  • Table of Contents
  • Introduction 
  • Therapeutics Development
  • Early Stage Products
  • AstraZeneca PLC 
  • Intra-Cellular Therapies, Inc.
  • SK Biopharmaceuticals Co., Ltd.
  • Product Description 
  • Get full TOC at http//www.reportsandintelligence
    .com/bipolar-disorder-manic-depression-pipeline-re
    view-h2-2014-market/table-of-contents


6

FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/bipolar-diso
rder-manic-depression-pipeline-review-h2-2014-mark
et
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE Direct 1 (617) 674-4143 Toll Free
1 (855) 711-1555E-MAIL sales_at_reportsandintellig
ence.com
Write a Comment
User Comments (0)
About PowerShow.com